Upgradeable Firmware: The Cochlear™ Nucleus ® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates.
Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...
It is hard to get excited after looking at Cochlear's (ASX:COH) recent performance, when its stock has declined 7.6% over the past three months. However, a closer look at its sound financials might ...
Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...
LONE TREE, Colo., March 3, 2025 /PRNewswire/ — In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number ...
Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.
CENTENNIAL, Colo., June 17, 2019 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration's (FDA) approval ...
Cochlear Limited (AU:COH) has released an update. Cochlear Limited recently reported changes in the interests of its director, Diggory William Howitt, involving the acquisition of 11,000 shares and ...
Cochlear (ASX:COH) has had a rough three months with its share price down 16%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially ...
Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...
Cochlear Limited (AU:COH) has released an update. Cochlear Limited has announced a new issuance of ordinary shares, with 94 securities set to be quoted on the Australian Securities Exchange on October ...
MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology, which specializes in the development of novel ...